Astrazeneca Pharma India standalone net profit rises 57.94% in the September 2019 quarter
Sales rise 29.20% to Rs 208.48 crore
Net profit of Astrazeneca Pharma India rose 57.94% to Rs 14.42 crore in the quarter ended September 2019 as against Rs 9.13 crore during the previous quarter ended September 2018. Sales rose 29.20% to Rs 208.48 crore in the quarter ended September 2019 as against Rs 161.36 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales208.48161.36 29 OPM %16.109.15 -PBDT36.4418.11 101 PBT31.8014.44 120 NP14.429.13 58Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 11 2019 | 4:51 PM IST